MPCI Wait for the downtrend to break, then buy
Use the right capital management and follow the rules of risk management.. it will protect your capital
25.914EGP
90.44 MEGP
663.83 MEGP
1.21 M
About MEMPHIS PHARMACEUTICALS
Sector
CEO
Basem Mohamed Abdullah
Headquarters
Cairo
Website
Founded
1940
ISIN
EGS38351C010
FIGI
BBG000HGL3D1
Memphis Pharmaceutical & Chemical Industries engages in the manufacture of medicines and other pharmaceutical products for human and veterinary use. Its products include effervescent tablets, syrup, cream, injections, tablet and capsules, and suppository. The company was founded on July 20, 1940 and is headquartered in Cairo, Egypt.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MPCI is 97.75 EGP — it has increased by 3.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange MEMPHIS PHARMACEUTICALS stocks are traded under the ticker MPCI.
Yes, you can track MEMPHIS PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
Like other stocks, MPCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEMPHIS PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEMPHIS PHARMACEUTICALS EBITDA is 192.00 M EGP, and current EBITDA margin is 21.21%. See more stats in MEMPHIS PHARMACEUTICALS financial statements.